Results 101 to 110 of about 74,680 (298)
, 2014 Prevalence of polypharmacy, major polypharmacy, and excessive polypharmacy among Korean elderly (aged ≥65 years) subjects (total 319,185).
Hong-Ah Kim (575718) +3 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Safe prescribing and effective medication review during acute hospitalization depends on accurate information about liver and kidney function because these organs are responsible for the elimination of most medications. While estimates for kidney function are widely used, comparable markers of hepatic drug‐metabolizing capacity are not routinely ...
Louise Westberg Strejby Christensen +17 more
wiley +1 more source
Current Therapeutic Research: Background: Understanding the rate of polypharmacy in cardiovascular patients is crucial because of its increasing occurrence and its association with potentially inappropriate prescribing practices and negative health outcomes, particularly among ...
Shambel Nigussie, MSc +1 more
doaj +1 more source
Prevalence of polypharmacy: Comparing the status of Indian states
Indian Journal of Community and Family Medicine, 2019 Introduction: The word “poly” is Greek and means many or much. However, the term polypharmacy has been given definitions connected both to the use of more than a certain number of drugs concomitantly and to the clinical appropriateness of drug use ...
Priya Sharma, N L Gupta, H S Chauhan
doaj +1 more source
, 2017 The use of polypharmacy (multiple medicines) is increasingly common in older people. There is no consensus on a clinical definition of polypharmacy and so it is often defined using a simple numerical threshold.
Gerri Kaufman
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway +2 more
wiley +1 more source
Rates, variability, and associated factors of polypharmacy in nursing home patients
, 2013 Yichayaou Beloosesky,1,3 Olga Nenaydenko,2 Revital Feige Gross Nevo,1,3 Abraham Adunsky,2,3 Avraham Weiss1,3 1Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Petah Tikva, 2Department of Geriatric Rehabilitation, Sheba Medical Center ...
Beloosesky Y +4 more
core
Polypharmacy in the HIV-infected older adult population
, 2013 Lauren J Gleason1, Amneris E Luque2, Krupa Shah1 1Division of Geriatrics and Aging, Highland Hospital, Rochester, NY, USA; 2Division of Infectious Disease, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY ...
Gleason LJ, Luque AE, Shah K
core
British Journal of Clinical Pharmacology, EarlyView.Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou +10 more
wiley +1 more source
Polypharmacy and super-polypharmacy in the under 65s – a scoping review of characteristics, risk and deprescribing ...
Jalpesh Trivedi
core +1 more source